S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
Log in
NYSEAMERICAN:STXS

Stereotaxis Stock Forecast, Price & News

$7.95
+0.95 (+13.57 %)
(As of 03/1/2021 12:00 AM ET)
Add
Compare
Today's Range
$7.11
Now: $7.95
$8.48
50-Day Range
$4.42
MA: $5.02
$5.30
52-Week Range
$1.70
Now: $7.95
$8.48
Volume1.62 million shs
Average Volume388,541 shs
Market Capitalization$585.80 million
P/E RatioN/A
Dividend YieldN/A
Beta1.56
Stereotaxis, Inc. designs, manufactures, and markets robotic magnetic navigation (RMN) systems for use in hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease in the United States and internationally. Its RMN systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites; and Vdrive system that offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also provides Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane and full-power x-ray system, including c-arm, powered table, motorized boom, and large high-definition monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company provides various disposable components V-Loop, V-Sono, and V-CAS devices; and V-CAS Deflect catheter advancement systems. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to develop a next-generation magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.
Stereotaxis logo

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:STXS
CUSIPN/A
CIKN/A
Phone314 678 6100
Employees118
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$28.90 million
Book Value$0.34 per share

Profitability

Net Income$-4,590,000.00

Miscellaneous

Market Cap$585.80 million
Next Earnings Date5/4/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

0.59 out of 5 stars

Medical Sector

1349th out of 1,966 stocks

Electromedical Equipment Industry

40th out of 61 stocks

Analyst Opinion: 1.5Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.6 5 -4 -3 -2 -1 -
$7.95
+0.95 (+13.57 %)
(As of 03/1/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive STXS News and Ratings via Email

Sign-up to receive the latest news and ratings for STXS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Stereotaxis (NYSEAMERICAN:STXS) Frequently Asked Questions

Is Stereotaxis a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Stereotaxis in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Stereotaxis stock.
View analyst ratings for Stereotaxis
or view top-rated stocks.

What stocks does MarketBeat like better than Stereotaxis?

Wall Street analysts have given Stereotaxis a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Stereotaxis wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Stereotaxis' next earnings date?

Stereotaxis is scheduled to release its next quarterly earnings announcement on Tuesday, May 4th 2021.
View our earnings forecast for Stereotaxis
.

How were Stereotaxis' earnings last quarter?

Stereotaxis, Inc. (NYSEAMERICAN:STXS) posted its earnings results on Thursday, February, 25th. The company reported ($0.02) EPS for the quarter, meeting the consensus estimate of ($0.02). Stereotaxis had a negative net margin of 24.54% and a negative trailing twelve-month return on equity of 22.78%.
View Stereotaxis' earnings history
.

How has Stereotaxis' stock price been impacted by Coronavirus (COVID-19)?

Stereotaxis' stock was trading at $3.78 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, STXS stock has increased by 110.3% and is now trading at $7.95.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for STXS?

3 equities research analysts have issued 12-month target prices for Stereotaxis' shares. Their forecasts range from $6.00 to $9.00. On average, they expect Stereotaxis' stock price to reach $7.33 in the next year. This suggests that the stock has a possible downside of 7.8%.
View analysts' price targets for Stereotaxis
or view top-rated stocks among Wall Street analysts.

Who are Stereotaxis' key executives?

Stereotaxis' management team includes the following people:
  • Mr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A., CFA, CPA, CEO & Chairman (Age 34)
  • Ms. Kimberly R. Peery, Chief Financial Officer

Who are some of Stereotaxis' key competitors?

What is Stereotaxis' stock symbol?

Stereotaxis trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "STXS."

Who are Stereotaxis' major shareholders?

Stereotaxis' stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (3.75%), Rhenman & Partners Asset Management AB (0.77%), Northern Trust Corp (0.73%), Roubaix Capital LLC (0.65%), Wells Fargo & Company MN (0.34%) and Essex Investment Management Co. LLC (0.29%). Company insiders that own Stereotaxis stock include David Benfer and Paul J Isaac.
View institutional ownership trends for Stereotaxis
.

Which institutional investors are selling Stereotaxis stock?

STXS stock was sold by a variety of institutional investors in the last quarter, including Essex Investment Management Co. LLC, Squarepoint Ops LLC, Exchange Traded Concepts LLC, Northern Trust Corp, Marathon Capital Management, Barclays PLC, and Zebra Capital Management LLC. Company insiders that have sold Stereotaxis company stock in the last year include David Benfer, and Paul J Isaac.
View insider buying and selling activity for Stereotaxis
or view top insider-selling stocks.

Which institutional investors are buying Stereotaxis stock?

STXS stock was acquired by a variety of institutional investors in the last quarter, including Rhenman & Partners Asset Management AB, Roubaix Capital LLC, BlackRock Inc., JPMorgan Chase & Co., Bank of New York Mellon Corp, Wells Fargo & Company MN, Credit Suisse AG, and Dimensional Fund Advisors LP.
View insider buying and selling activity for Stereotaxis
or or view top insider-buying stocks.

How do I buy shares of Stereotaxis?

Shares of STXS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Stereotaxis' stock price today?

One share of STXS stock can currently be purchased for approximately $7.95.

How much money does Stereotaxis make?

Stereotaxis has a market capitalization of $585.80 million and generates $28.90 million in revenue each year. The company earns $-4,590,000.00 in net income (profit) each year or ($0.10) on an earnings per share basis.

How many employees does Stereotaxis have?

Stereotaxis employs 118 workers across the globe.

What is Stereotaxis' official website?

The official website for Stereotaxis is www.stereotaxis.com.

Where are Stereotaxis' headquarters?

Stereotaxis is headquartered at 4320 FOREST PARK AVENUE SUITE 100, ST.LOUIS MO, 63108.

How can I contact Stereotaxis?

Stereotaxis' mailing address is 4320 FOREST PARK AVENUE SUITE 100, ST.LOUIS MO, 63108. The company can be reached via phone at 314 678 6100 or via email at [email protected]


This page was last updated on 3/2/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.